Colby Morton, NP
Nurse Practitioner · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 2 carriers
- Office
- 1
Offices
1 location
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Colby Morton’s office at (559) 216-0407 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
Original Medicare doctor bills
$79,544
Medicare paid this office $79,544 for 224 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 151 | $29,149 | $81 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 195 | $18,452 | $41 |
| New patient visit (60+ min) | 70 | $9,825 | $140 |
| New patient visit (45+ min) | 85 | $9,281 | $109 |
| Short return visit (20+ min) | 48 | $3,780 | $58 |
See all 8 services
| Return visit (30+ min) | 151 | $29,149 | $81 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 195 | $18,452 | $41 |
| New patient visit (60+ min) | 70 | $9,825 | $140 |
| New patient visit (45+ min) | 85 | $9,281 | $109 |
| Short return visit (20+ min) | 48 | $3,780 | $58 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | 31 | $2,214 | $55 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 34 | $1,464 | $22 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 35 | $1,439 | $21 |
Who their Medicare patients are
224 Original Medicare patients in 2024. Average age 68 · Under 65 24% · 85 and older 8% · Women 70% · Also on Medicaid 66% · Health risk score 1.88. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 74% · Chronic kidney disease 46% · Coronary heart disease 37% · Depression 27% · Heart failure 19% · COPD 14% · Atrial fibrillation 14% · Cancer 13% · Stroke 7% · Dementia 6%.
The office billed $199,430, Medicare allowed $105,628 and paid $79,544; for 1,396 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 224 | 1,396 | 68 | 1.88 | $199,430 | $79,544 |
| 2023 | 80 | 1,899 | 67 | 1.47 | $51,895 | $23,431 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 55 | $10,679 | $88 |
| New patient visit (60+ min) | 37 | $5,579 | $151 |
| New patient visit (45+ min) | 29 | $3,202 | $110 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 28 | $1,461 | $42 |
| Diabetes outpatient self-management training services, individual, per 30 minutes | 16 | $890 | $45 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 12 | $564 | $23 |
Medicaid work
$4,406 in 2024
Medicaid paid $4,406 for 3,863 billed services this clinician did in 2024, up to 137 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 1,027 | $1,335 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 1,166 | $1,007 |
| Diabetes outpatient self-management training services, individual, per 30 minutes | 810 | $869 |
| New patient visit (45+ min) | 226 | $784 |
| New patient visit (60+ min) | 107 | $165 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; analysis, interpretation and report | 192 | $160 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 163 | $45 |
| Short return visit (20+ min) | 135 | $24 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 37 | $16 |
| 2024 | 3,863 | 9 | 137 | $4,406 |
| 2023 | 882 | 7 | 65 | $1,573 |
| 2018 | 191 | 4 | 97 | $12,416 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 275 | $495 |
| New patient visit (45+ min) | 74 | $276 |
| Diabetes outpatient self-management training services, individual, per 30 minutes | 226 | $274 |
| New patient visit (60+ min) | 88 | $272 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 148 | $199 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; analysis, interpretation and report | 34 | $34 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 37 | $22 |
2018
| Clinic visit/encounter, all-inclusive | 105 | $12,271 |
| Short return visit | 54 | $72 |
| Short return visit (20+ min) | 16 | $72 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 16 | $0 |
Drugs they prescribed that Part D paid
$1,235,644
Pharmacies billed $1,235,644 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (19 of 1,592) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
582 generic and 866 brand-name prescriptions · $1,235,644 in drug cost · 18 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Korlym | 14 | $416,843 | $29,775 |
| Ozempic | 171 | $266,722 | $1,560 |
| Mounjaro | 46 | $72,876 | $1,584 |
| Jardiance | 41 | $50,651 | $1,235 |
| Tresiba Flextouch U-200 | 28 | $42,416 | $1,515 |
See all 30 drugs
| Korlym | 14 | $416,843 | $29,775 |
| Ozempic | 171 | $266,722 | $1,560 |
| Mounjaro | 46 | $72,876 | $1,584 |
| Jardiance | 41 | $50,651 | $1,235 |
| Tresiba Flextouch U-200 | 28 | $42,416 | $1,515 |
| Farxiga | 38 | $38,223 | $1,006 |
| Rybelsus | 12 | $25,700 | $2,142 |
| Tresiba Flextouch U-100 | 41 | $21,791 | $531 |
| Synjardy Xr | 15 | $20,686 | $1,379 |
| Humalog Kwikpen U-100 | 54 | $19,371 | $359 |
| Basaglar Kwikpen U-100 | 50 | $18,560 | $371 |
| Xigduo Xr | 17 | $18,245 | $1,073 |
| Toujeo Max Solostar | 18 | $13,776 | $765 |
| Fiasp Flextouch | 14 | $12,530 | $895 |
| Lantus Solostar | 79 | $11,788 | $149 |
| Nano 2nd Gen Pen Needle | 96 | $10,324 | $108 |
| Novolog Flexpen | 25 | $6,813 | $273 |
| Humalog | 15 | $6,526 | $435 |
| Insulin Lispro Kwikpen U-100 | 15 | $4,779 | $319 |
| Droplet Pen Needle | 12 | $1,187 | $99 |
| Levothyroxine | 106 | $984 | $9 |
| Amitriptyline | 49 | $508 | $10 |
| Methimazole | 49 | $465 | $9 |
| Metformin | 69 | $459 | $7 |
| Gabapentin | 19 | $350 | $18 |
| Atorvastatin | 22 | $132 | $6 |
| Lisinopril | 18 | $71 | $4 |
| Zolpidem | 15 | $57 | $4 |
| Tramadol | 16 | $26 | $2 |
| Dexamethasone | 13 | $5 | $0 |
Year by year
| 2024 | 1,592 | 268 | 1% (19) | 54% | $1,235,644 |
| 2023 | 524 | 99 | 2% (11) | 40% | $405,272 |
| 2022 | 36 | 12 | None | 69% | $18,970 |
| 2021 | 160 | 57 | 36% (58) | None | $16,652 |
| 2020 | 331 | 116 | 35% (116) | 15% | $71,014 |
| 2019 | 616 | 176 | 31% (192) | None | $66,678 |
| 2018 | 499 | 116 | 24% (122) | 8% | $19,495 |
| 2017 | 128 | 33 | None | None | $1,713 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Ozempic | 27 | $41,631 | $1,542 |
| Novolog Flexpen | 18 | $28,647 | $1,592 |
| Lantus Solostar | 27 | $22,965 | $851 |
| Humalog Kwikpen U-100 | 12 | $16,624 | $1,385 |
| Xigduo Xr | 12 | $12,936 | $1,078 |
| Basaglar Kwikpen U-100 | 15 | $5,863 | $391 |
| Nano 2nd Gen Pen Needle | 28 | $2,898 | $103 |
| Levothyroxine | 21 | $439 | $21 |
| Metformin | 24 | $378 | $16 |
| Methimazole | 19 | $373 | $20 |
| Atorvastatin | 14 | $343 | $24 |
| Amitriptyline | 18 | $237 | $13 |
| Tramadol | 11 | $49 | $4 |
| Zolpidem | 13 | $23 | $2 |
2021: 2 drugs
| Methylphenidate | 43 | $1,625 | $38 |
| Hydrocodone-Acetaminophen | 48 | $1,014 | $21 |
2020: 6 drugs
| Methylphenidate | 42 | $1,814 | $43 |
| Hydrocodone-Acetaminophen | 96 | $1,751 | $18 |
| Morphine Sulfate Er | 11 | $1,399 | $127 |
| Testosterone Cypionate | 17 | $945 | $56 |
| Dextroamphetamine-Amphetamine | 17 | $613 | $36 |
| Alprazolam | 18 | $112 | $6 |
2019: 11 drugs
| Hydrocodone-Acetaminophen | 126 | $2,912 | $23 |
| Testosterone Cypionate | 44 | $2,528 | $57 |
| Methylphenidate | 49 | $2,357 | $48 |
| Dextroamphetamine-Amphetamine | 27 | $1,377 | $51 |
| Methylphenidate Hcl Er (Cd) | 11 | $1,371 | $125 |
| Diphenoxylate-Atropine | 14 | $1,175 | $84 |
| Oxycodone-Acetaminophen | 23 | $987 | $43 |
| Alprazolam | 87 | $731 | $8 |
| Morphine Sulfate Er | 11 | $543 | $49 |
| Zolpidem | 33 | $265 | $8 |
| Amlodipine Besylate | 11 | $69 | $6 |
2018: 11 drugs
| Hydrocodone-Acetaminophen | 70 | $2,269 | $32 |
| Methylphenidate | 19 | $1,225 | $64 |
| Dextroamphetamine-Amphetamine | 26 | $1,208 | $46 |
| Testosterone Cypionate | 15 | $1,128 | $75 |
| Levothyroxine | 16 | $456 | $29 |
| Alprazolam | 33 | $326 | $10 |
| Amlodipine Besylate | 25 | $134 | $5 |
| Losartan | 21 | $124 | $6 |
| Atorvastatin | 16 | $124 | $8 |
| Zolpidem | 14 | $121 | $9 |
| Metformin | 11 | $57 | $5 |
2017: 1 drug
| Lisinopril | 21 | $102 | $5 |
Money from drug and device companies
$14,043 in 2025
| 2025 | 24 | 159 | $11,425 | $14,043 |
| 2024 | 20 | 84 | $15,250 | $17,288 |
| 2023 | 22 | 62 | $22,850 | $24,771 |
| 2022 | 20 | 81 | $35,550 | $37,215 |
| 2021 | 23 | 153 | $10,275 | $13,244 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Minimed 780g | $11,517 | 39 payments
|
| Xeris Pharmaceuticals | Recorlev | $473 | 21 payments
|
| Amgen | Tepezza | $455 | 24 payments
|
| Corcept Therapeutics | Korlym | $173 | 6 payments
|
| Ascendis Pharma Endocrinology | Yorvipath | $169 | 8 payments
|
| Alexion Pharmaceuticals | Strensiq | $159 | 6 payments
|
See all 157 published payments
| Insulet | Meals · 2025-12-19 | Omnipod | $24 |
| Amgen | Meals · 2025-12-18 | Tepezza | $7 |
| Corcept Therapeutics | Meals · 2025-12-10 | Korlym | $23 |
| Xeris Pharmaceuticals | Meals · 2025-12-09 | Gvoke Hypopen | $23 |
| Amgen | Meals · 2025-12-08 | Tepezza | $16 |
| Xeris Pharmaceuticals | Meals · 2025-12-05 | Recorlev | $8 |
| Novo Nordisk | Meals · 2025-12-04 | Wegovy | $5 |
| Amgen | Meals · 2025-12-04 | Krystexxa | $25 |
| Ascendis Pharma Endocrinology | Meals · 2025-12-02 | Yorvipath | $25 |
| Amgen | Meals · 2025-11-21 | Tepezza | $27 |
| Alexion Pharmaceuticals | Meals · 2025-11-18 | Strensiq | $31 |
| Corcept Therapeutics | Meals · 2025-11-15 | Korlym | $31 |
| Amgen | Meals · 2025-11-13 | Krystexxa | $27 |
| Xeris Pharmaceuticals | Meals · 2025-11-13 | Recorlev | $9 |
| Recordati Rare Diseases Inc. | Meals · 2025-11-11 | Isturisa | $24 |
| Xeris Pharmaceuticals | Meals · 2025-10-30 | Recorlev | $21 |
| Medtronic | Meals · 2025-10-27 | Minimed 780g | $21 |
| Amgen | Meals · 2025-10-27 | Tepezza | $8 |
| Novo Nordisk | Meals · 2025-10-24 | Wegovy | $6 |
| Corcept Therapeutics | Meals · 2025-10-23 | Korlym | $33 |
| Novo Nordisk | Meals · 2025-10-20 | Ozempic | $17 |
| Amgen | Meals · 2025-10-09 | Tepezza | $6 |
| Xeris Pharmaceuticals | Meals · 2025-10-09 | Recorlev | $11 |
| Ascendis Pharma Endocrinology | Meals · 2025-10-07 | Yorvipath | $14 |
| Medtronic | Meals · 2025-09-25 | Minimed 780g | $25 |
| Radius Health | Meals · 2025-09-24 | Tymlos | $32 |
| Sequel Med Tech | Meals · 2025-09-22 | Twiist | $33 |
| Corcept Therapeutics | Meals · 2025-09-18 | Korlym | $41 |
| Amgen | Meals · 2025-09-18 | Tepezza | $9 |
| Xeris Pharmaceuticals | Meals · 2025-09-18 | Recorlev | $11 |
| Abbvie | Meals · 2025-09-17 | Lupron Depot | $20 |
| Ascendis Pharma Endocrinology | Meals · 2025-09-17 | Yorvipath | $9 |
| Alexion Pharmaceuticals | Meals · 2025-09-15 | Strensiq | $28 |
| Novo Nordisk | Meals · 2025-09-10 | Wegovy | $7 |
| Xeris Pharmaceuticals | Meals · 2025-09-09 | Gvoke Hypopen | $19 |
| Soleno Therapeutics | Meals · 2025-09-03 | Vykat Xr | $35 |
| Corcept Therapeutics | Meals · 2025-08-28 | Korlym | $28 |
| Novo Nordisk | Meals · 2025-08-26 | Wegovy | $5 |
| Amgen | Meals · 2025-08-26 | Tepezza | $26 |
| Sanofi-Aventis U.S. | Meals · 2025-08-26 | Tzield | $8 |
| Lilly USA | Meals · 2025-08-25 | Mounjaro | $7 |
| Chiesi USA | Meals · 2025-08-22 | Juxtapid | $28 |
| Xeris Pharmaceuticals | Meals · 2025-08-21 | Recorlev | $20 |
| Alexion Pharmaceuticals | Meals · 2025-08-20 | Strensiq | $23 |
| Novo Nordisk | Meals · 2025-08-18 | Ozempic | $24 |
| Amgen | Meals · 2025-08-13 | Tepezza | $6 |
| Dexcom | Meals · 2025-08-12 | Dexcom G6 Transmitter | $16 |
| Amgen | Meals · 2025-08-07 | Tepezza | $10 |
| Amgen | Meals · 2025-08-06 | Krystexxa | $16 |
| Mannkind | Meals · 2025-08-06 | Afrezza | $17 |
| Lilly USA | Meals · 2025-08-04 | Mounjaro | $11 |
| Insulet | Meals · 2025-07-30 | Omnipod | $22 |
| Ascendis Pharma Endocrinology | Meals · 2025-07-23 | Yorvipath | $25 |
| Amgen | Meals · 2025-07-15 | Tepezza | $16 |
| Lilly USA | Meals · 2025-07-10 | Mounjaro | $17 |
| Xeris Pharmaceuticals | Meals · 2025-07-07 | Gvoke Hypopen | $14 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $200 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $225 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $225 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $225 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $225 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $225 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $225 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $225 |
| Medtronic | Paid to speak or teach · 2025-07-02 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-07-01 | Minimed 780g | $225 |
| Medtronic | Paid to speak or teach · 2025-07-01 | Minimed 780g | $200 |
| Medtronic | Paid to speak or teach · 2025-07-01 | Minimed 780g | $225 |
| Medtronic | Paid to speak or teach · 2025-07-01 | Minimed 780g | $225 |
| Corcept Therapeutics | Meals · 2025-06-27 | Korlym | $18 |
| Madrigal Pharmaceuticals | Meals · 2025-06-27 | Rezdiffra | $103 |
| Sanofi-Aventis U.S. | Meals · 2025-06-24 | Tzield | $29 |
| Tandem Diabetes Care | Meals · 2025-06-23 | T:Slim X2 Insulin Pump With Control-Iq | $31 |
| Soleno Therapeutics | Meals · 2025-06-19 | Vykat Xr | $22 |
| Lilly USA | Meals · 2025-06-16 | Mounjaro | $15 |
| Amgen | Meals · 2025-06-12 | Tepezza | $26 |
| Amgen | Meals · 2025-06-12 | Tepezza | $29 |
| Alexion Pharmaceuticals | Meals · 2025-06-11 | Strensiq | $17 |
| Xeris Pharmaceuticals | Meals · 2025-06-11 | Recorlev | $19 |
| Lilly USA | Meals · 2025-06-05 | Jardiance | $15 |
| Sanofi-Aventis U.S. | Meals · 2025-06-05 | Tzield | $27 |
| Ascendis Pharma Endocrinology | Meals · 2025-05-30 | Yorvipath | $28 |
| Sanofi-Aventis U.S. | Meals · 2025-05-28 | Tzield | $7 |
| Xeris Pharmaceuticals | Meals · 2025-05-28 | Recorlev | $8 |
| Xeris Pharmaceuticals | Meals · 2025-05-20 | Gvoke Hypopen | $19 |
| Amgen | Meals · 2025-05-16 | Tepezza | $10 |
| Medtronic | Paid to speak or teach · 2025-05-15 | Minimed 780g | $425 |
| Alexion Pharmaceuticals | Meals · 2025-05-14 | Strensiq | $33 |
| Lilly USA | Meals · 2025-05-13 | Mounjaro | $22 |
| Novo Nordisk | Meals · 2025-05-12 | Ozempic | $30 |
| Amgen | Meals · 2025-05-07 | Krystexxa | $99 |
| Soleno Therapeutics | Meals · 2025-05-07 | Vykat Xr | $22 |
| Xeris Pharmaceuticals | Meals · 2025-05-07 | Recorlev | $7 |
| Tandem Diabetes Care | Meals · 2025-05-06 | T:Slim X2 Insulin Pump With Control-Iq | $29 |
| Sanofi-Aventis U.S. | Meals · 2025-05-01 | Tzield | $6 |
| Ascendis Pharma Endocrinology | Meals · 2025-05-01 | Yorvipath | $20 |
| Neurocrine BioSciences | Meals · 2025-05-01 | Crenessity | $25 |
| Lilly USA | Meals · 2025-04-29 | Mounjaro | $12 |
| Medtronic | Meals · 2025-04-29 | Minimed 780g | $27 |
| Amgen | Meals · 2025-04-24 | Tepezza | $8 |
| Xeris Pharmaceuticals | Meals · 2025-04-23 | Recorlev | $23 |
| Mannkind | Education · 2025-04-18 | Afrezza | $43 |
| Mannkind | Meals · 2025-04-17 | Afrezza | $31 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-15 | Breztri | $20 |
| Abbott Laboratories | Meals · 2025-04-08 | Freestyle Libre 3 | $14 |
| Amgen | Meals · 2025-04-01 | Tepezza | $7 |
| Dexcom | Meals · 2025-04-01 | Dexcom G6 Transmitter | $18 |
| Ascendis Pharma Endocrinology | Meals · 2025-03-31 | Yorvipath | $29 |
| Xeris Pharmaceuticals | Meals · 2025-03-25 | Gvoke Hypopen | $20 |
| Amgen | Meals · 2025-03-24 | Tepezza | $17 |
| Medtronic | Paid to speak or teach · 2025-03-20 | Minimed 780g | $425 |
| Novo Nordisk | Meals · 2025-03-19 | Wegovy | $7 |
| Lilly USA | Meals · 2025-03-17 | Mounjaro | $10 |
| Medtronic | Paid to speak or teach · 2025-03-17 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-03-17 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-03-17 | Minimed 780g | $425 |
| Xeris Pharmaceuticals | Meals · 2025-03-13 | Recorlev | $17 |
| Amgen | Meals · 2025-03-11 | Tepezza | $10 |
| Ascendis Pharma Endocrinology | Meals · 2025-03-06 | Yorvipath | $20 |
| Tandem Diabetes Care | Meals · 2025-03-05 | T:Slim X2 Insulin Pump With Control-Iq | $31 |
| Sanofi-Aventis U.S. | Meals · 2025-02-26 | Tzield | $22 |
| Novo Nordisk | Meals · 2025-02-24 | Ozempic | $20 |
| Medtronic | Paid to speak or teach · 2025-02-20 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-02-20 | Minimed 780g | $225 |
| Medtronic | Paid to speak or teach · 2025-02-20 | Minimed 780g | $225 |
| Alexion Pharmaceuticals | Meals · 2025-02-19 | Strensiq | $28 |
| Sanofi-Aventis U.S. | Meals · 2025-02-19 | Tzield | $5 |
| Xeris Pharmaceuticals | Meals · 2025-02-19 | Recorlev | $8 |
| Lilly USA | Meals · 2025-02-17 | Mounjaro | $10 |
| Medtronic | Paid to speak or teach · 2025-02-11 | Minimed 780g | $425 |
| Sanofi-Aventis U.S. | Meals · 2025-02-06 | Tzield | $32 |
| Novo Nordisk | Meals · 2025-02-05 | Ozempic | $20 |
| Xeris Pharmaceuticals | Meals · 2025-01-29 | Recorlev | $6 |
| Neurocrine BioSciences | Meals · 2025-01-28 | Crenessity | $26 |
| Amgen | Meals · 2025-01-24 | Tepezza | $29 |
| Novo Nordisk | Meals · 2025-01-22 | Wegovy | $7 |
| Sanofi-Aventis U.S. | Meals · 2025-01-22 | Tzield | $9 |
| Xeris Pharmaceuticals | Meals · 2025-01-21 | Gvoke Hypopen | $19 |
| Xeris Pharmaceuticals | Meals · 2025-01-16 | Recorlev | $11 |
| Xeris Pharmaceuticals | Meals · 2025-01-15 | Recorlev | $180 |
| Ultragenyx Pharmaceutical | Meals · 2025-01-15 | Crysvita | $21 |
| Amgen | Meals · 2025-01-10 | Krystexxa | $15 |
| Medtronic | Meals · 2025-01-08 | Minimed 780g | $20 |
| Amgen | Meals · 2025-01-07 | Tepezza | $5 |
| Medtronic | Paid to speak or teach · 2025-01-02 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-01-02 | Minimed 780g | $225 |
| Medtronic | Paid to speak or teach · 2025-01-02 | Minimed 780g | $225 |
| Medtronic | Paid to speak or teach · 2025-01-02 | Minimed 780g | $425 |
| Medtronic | Paid to speak or teach · 2025-01-02 | Minimed 780g | $225 |
See earlier years (2024, 2023, 2022, 2021)
2024: $17,288
| Medtronic | Minimed 780g | $15,274 | 5 payments
|
| Amgen | Tepezza | $514 | 20 payments
|
| Lilly USA | Mounjaro | $209 | 8 payments
|
| Alexion Pharmaceuticals | Strensiq | $198 | 8 payments
|
| Sanofi-Aventis U.S. | Tzield | $188 | 7 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $167 | 4 payments
|
| Xeris Pharmaceuticals | Recorlev | $132 | 7 payments
|
| Corcept Therapeutics | Korlym | $125 | 1 payment
|
| Abbott Laboratories | Proclaim | $107 | 5 payments
|
| Mannkind | Afrezza | $84 | 4 payments
|
| Kyowa Kirin | Crysvita | $53 | 2 payments
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $45 | 2 payments
|
| Abbvie | Synthroid | $36 | 2 payments
|
| Radius Health | None | $30 | 1 payment
|
| Ascensia Diabetes Care Us | Eversense 365 Sensor Kit (Retail) | $24 | 1 payment
|
| Novo Nordisk | None | $23 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $23 | 1 payment
|
| Ultragenyx Pharmaceutical | Crysvita | $20 | 1 payment
|
| CeQur | Cequr Simplicity | $18 | 1 payment
|
| Neurocrine Biosciences | None | $15 | 1 payment
|
2023: $24,771
| Medtronic | Minimed 780g | $23,315 | 9 payments
|
| Corcept Therapeutics | Korlym | $246 | 3 payments
|
| Dexcom | Dexcom G6 Transmitter | $229 | 6 payments
|
| Lilly USA | Baqsimi | $164 | 9 payments
|
| Horizon Therapeutics plc | Tepezza | $140 | 2 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $77 | 4 payments
|
| Kyowa Kirin | Crysvita | $67 | 3 payments
|
| Novo Nordisk | Ozempic | $62 | 3 payments
|
| Nevro | Senza | $61 | 2 payments
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $59 | 3 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $55 | 3 payments
|
| Abbvie | Lupron Depot | $53 | 3 payments
|
| MannKind | Afrezza | $44 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $40 | 2 payments
|
| Tolmar | Fensolvi | $28 | 1 payment
|
| Ascendis Pharma | None | $23 | 1 payment
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $22 | 1 payment
|
| Alexion Pharmaceuticals | Strensiq | $21 | 1 payment
|
| Ultragenyx Pharmaceutical | None | $20 | 1 payment
|
| Nestle Healthcare Nutrition | Zenpep | $16 | 1 payment
|
| Insulet | Omnipod | $14 | 1 payment
|
| CeQur | Cequr Simplicity | $11 | 1 payment
|
2022: $37,215
| Medtronic | Minimed 770g | $35,705 | 8 payments
|
| Novo Nordisk | Rybelsus | $233 | 14 payments
|
| Lilly USA | Mounjaro | $200 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $152 | 3 payments
|
| Abbott Laboratories | Freestyle Libre 2 | $151 | 16 payments
|
| Antares Pharma | Tlando | $125 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $84 | 4 payments
|
| Corcept Therapeutics | Korlym | $81 | 4 payments
|
| Dexcom | Dexcom G6 Transmitter | $77 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $64 | 4 payments
|
| Sanofi-Aventis U.S. | Toujeo | $63 | 3 payments
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $48 | 2 payments
|
| Insulet | Omnipod | $45 | 2 payments
|
| Mannkind | Afrezza | $40 | 2 payments
|
| Xeris Pharmaceuticals | Gvoke Pfs | $37 | 2 payments
|
| Horizon Therapeutics plc | Tepezza | $25 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $25 | 1 payment
|
| Becton Dickinson and | Bd Nano 2nd Gen Pen Needle | $24 | 1 payment
|
| Nevro | Omnia | $19 | 1 payment
|
| Bigfoot Biomedical | Unity Diabetes Management System | $17 | 1 payment
|
2021: $13,244
| Medtronic | Minimed 770g System | $10,366 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $503 | 18 payments
|
| Novo Nordisk | Ozempic | $339 | 18 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $259 | 18 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $226 | 8 payments
|
| Lilly USA | Baqsimi | $210 | 13 payments
|
| Insulet | Omnipod | $199 | 13 payments
|
| Ultragenyx Pharmaceutical | None | $194 | 2 payments
|
| Corcept Therapeutics | Korlym | $180 | 9 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $123 | 6 payments
|
| Becton Dickinson and | Bd Nano | $117 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Tradjenta | $94 | 5 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $80 | 4 payments
|
| Radius Health | Tymlos | $60 | 2 payments
|
| Xeris Pharmaceuticals | Gvoke Pfs | $58 | 3 payments
|
| Horizon Therapeutics plc | Tepezza | $58 | 3 payments
|
| Dexcom | Dexcom G6 Transmitter | $50 | 2 payments
|
| Nevro | Omnia | $30 | 2 payments
|
| Pfizer | Cologuard Dna Capture Reagents | $25 | 1 payment
|
| MannKind | Afrezza | $23 | 1 payment
|
| Tandem Diabetes Care | T-Slim Insulin Pump | $18 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $18 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 2 | $14 | 1 payment
|
Professional record
- NPI
- 1124569991
- Licence
- CA 95004925
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 338 Vernon St, San Francisco, CA, 94132
- NPI first listed
- 2017-03-14
- NPI last updated
- 2023-04-11
- NPI record certified
- 2023-04-11
This is when the NPI record was last certified, not a medical board exam.